TGTX CIK: 1001316

TG Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−296
FY22:
−176
FY23:
−31.4
FY24:
−40.5
FY25:
−24.8
Change from FY21 to FY25
millions USD
FY21:
−0.33
FY22:
−20.0
FY23:
−50.7
FY24:
−1.04
FY25:
13.8
Change from FY21 to FY25
millions USD
FY21:
41.4
FY22:
−0.39
FY23:
72.7
FY24:
129
FY25:
−89.7
millions USD
FY21:
−255
FY22:
−197
FY23:
−9.36
FY24:
87.0
FY25:
−101
(positive)
Change from FY21 to FY25
millions USD
FY21:
−296
FY22:
−176
FY23:
−31.4
FY24:
−40.6
FY25:
−25.0

All amounts in millions USD Data source:SEC EDGAR